@article{ETD,
      recid = {658},
      author = {Merrill, Jeffrey},
      title = {Incorporation of uncertainty into a medical decision model  of erthropoietin use in premature infants at risk for red  cell transfusion},
      publisher = {Oregon Health and Science University},
      school = {M.B.I.},
      address = {2011},
      number = {ETD},
      abstract = {Premature infants are at risk of developing significant  anemia with adverse clinical outcome, yet blood  transfusions used to treat anemia carry additional risks.  Studies have investigated the use of recombinant  erythropoietin (r-Epo) to reduce the need for blood  transfusions. The beneficial impact of r-Epo use is  controversial, and the original studies and meta-analyses  were hampered by significant heterogeneity across trials,  particularly in gestational age/birth weight, r-Epo dose,  and transfusion criteria, as well as variation in the  quality of evidence.},
      url = {http://digitalcollections.ohsu.edu/record/658},
      doi = {https://doi.org/10.6083/M4V122ST},
}